Annual Total Liabilities
$20.98 M
-$186.29 M-89.88%
December 31, 2023
Summary
- As of February 7, 2025, RDHL annual total liabilities is $20.98 million, with the most recent change of -$186.29 million (-89.88%) on December 31, 2023.
- During the last 3 years, RDHL annual total liabilities has fallen by -$145.40 million (-87.39%).
- RDHL annual total liabilities is now -89.88% below its all-time high of $207.27 million, reached on December 31, 2022.
Performance
RDHL Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$21.96 M
-$9.60 M-30.42%
June 1, 2024
Summary
- As of February 7, 2025, RDHL quarterly total liabilities is $21.96 million, with the most recent change of -$9.60 million (-30.42%) on June 1, 2024.
- Over the past year, RDHL quarterly total liabilities has dropped by -$9.60 million (-30.42%).
- RDHL quarterly total liabilities is now -89.40% below its all-time high of $207.27 million, reached on December 31, 2022.
Performance
RDHL Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
RDHL Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -89.9% | -30.4% |
3 y3 years | -87.4% | -30.4% |
5 y5 years | +86.9% | -30.4% |
RDHL Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -89.9% | at low | -89.4% | at low |
5 y | 5-year | -89.9% | +48.8% | -89.4% | +55.8% |
alltime | all time | -89.9% | +1846.0% | -89.4% | +1937.4% |
RedHill Biopharma Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2024 | - | $21.96 M(-30.4%) |
Dec 2023 | $20.98 M(-89.9%) | - |
Jun 2023 | - | $31.57 M(-44.5%) |
Mar 2023 | - | $56.83 M(-72.6%) |
Dec 2022 | $207.27 M(+20.3%) | $207.27 M(+2.0%) |
Sep 2022 | - | $203.22 M(+13.0%) |
Jun 2022 | - | $179.91 M(+4.4%) |
Mar 2022 | - | $172.29 M(-0.0%) |
Dec 2021 | $172.31 M(+3.6%) | $172.31 M(-1.4%) |
Sep 2021 | - | $174.79 M(+0.4%) |
Jun 2021 | - | $174.09 M(+4.2%) |
Mar 2021 | - | $167.08 M(+0.4%) |
Dec 2020 | $166.38 M(+1080.2%) | $166.38 M(+18.6%) |
Sep 2020 | - | $140.24 M(+6.4%) |
Jun 2020 | - | $131.78 M(+32.0%) |
Mar 2020 | - | $99.83 M(+608.2%) |
Dec 2019 | $14.10 M(+25.6%) | $14.10 M(-19.0%) |
Sep 2019 | - | $17.39 M(-2.2%) |
Jun 2019 | - | $17.79 M(+9.4%) |
Mar 2019 | - | $16.26 M(+44.8%) |
Dec 2018 | $11.22 M | $11.22 M(-17.1%) |
Sep 2018 | - | $13.53 M(+13.3%) |
Jun 2018 | - | $11.94 M(+18.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2018 | - | $10.10 M(-17.7%) |
Dec 2017 | $12.28 M(+6.7%) | $12.28 M(-24.9%) |
Sep 2017 | - | $16.34 M(+23.9%) |
Jun 2017 | - | $13.18 M(+23.7%) |
Mar 2017 | - | $10.66 M(-7.4%) |
Dec 2016 | $11.51 M(+70.5%) | $11.51 M(+37.1%) |
Sep 2016 | - | $8.39 M(+15.4%) |
Jun 2016 | - | $7.28 M(+10.0%) |
Mar 2016 | - | $6.62 M(-2.0%) |
Dec 2015 | $6.75 M(+75.6%) | $6.75 M(+21.7%) |
Sep 2015 | - | $5.55 M(-17.9%) |
Jun 2015 | - | $6.76 M(-7.9%) |
Mar 2015 | - | $7.34 M(+90.9%) |
Dec 2014 | $3.85 M(+59.2%) | $3.85 M(-11.6%) |
Sep 2014 | - | $4.35 M(-21.9%) |
Jun 2014 | - | $5.57 M(+57.6%) |
Mar 2014 | - | $3.53 M(+46.3%) |
Dec 2013 | $2.42 M(+124.0%) | $2.42 M(+25.5%) |
Sep 2013 | - | $1.92 M(+9.3%) |
Jun 2013 | - | $1.76 M(+32.3%) |
Mar 2013 | - | $1.33 M(+23.5%) |
Dec 2012 | $1.08 M(-22.9%) | $1.08 M(-41.1%) |
Sep 2012 | - | $1.83 M(+30.9%) |
Dec 2011 | $1.40 M | $1.40 M |
FAQ
- What is RedHill Biopharma annual total liabilities?
- What is the all time high annual total liabilities for RedHill Biopharma?
- What is RedHill Biopharma annual total liabilities year-on-year change?
- What is RedHill Biopharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for RedHill Biopharma?
- What is RedHill Biopharma quarterly total liabilities year-on-year change?
What is RedHill Biopharma annual total liabilities?
The current annual total liabilities of RDHL is $20.98 M
What is the all time high annual total liabilities for RedHill Biopharma?
RedHill Biopharma all-time high annual total liabilities is $207.27 M
What is RedHill Biopharma annual total liabilities year-on-year change?
Over the past year, RDHL annual total liabilities has changed by -$186.29 M (-89.88%)
What is RedHill Biopharma quarterly total liabilities?
The current quarterly total liabilities of RDHL is $21.96 M
What is the all time high quarterly total liabilities for RedHill Biopharma?
RedHill Biopharma all-time high quarterly total liabilities is $207.27 M
What is RedHill Biopharma quarterly total liabilities year-on-year change?
Over the past year, RDHL quarterly total liabilities has changed by -$9.60 M (-30.42%)